Prof. George P Chrousos is internationally recognized for his research on the glucocorticoid signaling system of the cell, on the diseases of the hypothalamic-pituitary-adrenal axis, and on the physiological and molecular mechanisms of stress. He is one of the 250 most cited scientists internationally (ISI highly cited) included not only in the list of Clinical Medicine, but also in that of Biology and Biochemistry, and the highest cited clinical endocrinologist and pediatrician in the world.
Chairman of the Dept. of Pediatrics at National Jewish Health in Denver. Vice-Chairman of the Dept. of Pediatrics at the Univ. of Colorado Health Sciences Center. Recipient of the Mead Johnson Award for Research in Pediatrics, the McLaughlin Foundation Edward Gallie Professorship of the Royal College of Physicians and Surgeons of Canada, the Lifetime Achievement Award from National Jewish, and the Honorary Fellow Award from the American Academy of Allergy, Asthma and Immunology.
Professor for Pediatric Neurology at the University of Wisconsin Madison with previous appointments at the Humboldt University Berlin and Technical University Dresden, Germany. Recipient of the Ernst-Wiethoff prize (2000) and the Michael Prize for Epilepsy (2009)
John trained in paediatrics and nephrology in Sydney and London, then worked as an academic paediatric nephrologist at the Royal Alexandra Hospital for Children in Sydney, where he founded the Centre for Kidney Research. For four years he was Medical Director of the Australian Kidney Foundation. Then he worked in therapeutic risk management and pharmacovigilance for a decade for Johnson and Johnson in Europe and Asia. He returned to academia in 2014 as a Professorial Fellow at the George Institute for Global Health in Sydney, where he is also Director of China-Australia Partnerships. His current research concerns dialysis access and outcomes, particularly in resource constrained environments.
Main research Interests:
A) Asthma is a major cause of morbidity in the Western world but curative therapies do not exist. Hence, we aim to understand how early life environmental exposures modify lung development development and the risk of developing asthma throughout life. We use animal models of prenatal exposure to tobacco/nicotine products and human samples.
B) The importance of a steady-state balance of resident and non-resident bacterial communities for human health is increasingly appreciated. Yet, factors driving the composition of such microbial communities remain poorly understood. Therefore, we currently investigate the influence of smoke on the structure and functionality of the lung microbiome and its interaction with the lung health.
Currently Funded Projects
2012 – 2016 Chair of COST Action BM1201 “Developmental origins of Chronic Lung Disease” http://www.cost-early-origin-cld.eu/
2013 – 2016 Understanding the role of the lung microbiome for human health and diseases”, HMGU Environmental Health Projects, Co-PI until move to University of Kiel; Project currently continued on a collaborative basis.
Since 2013 – 2018 PI within German Center for Lung Research www.dzl.de
2016 - 2018 Chair of “The lung Microbiota at the Interface between airway epithelium and the environment” funded by the Leibniz Association
Epidemiologist and (former) pediatrician and neonatologist. Research interests include childhood obesity, perinatal epidemiology, and pediatric thrombosis and hemostasis.
Angela is a speech neuroscientist studying the neurobiological bases of childhood speech and language disorders.
Associate Professor, Washington University School of Medicine, Saint Louis, MO.
Department of Pediatrics (Infectious Diseases). Department of Microbiology.
The primary research goals of our lab are to understand the biological functions of specific metabolic pathways in the malaria parasite--that is, to understand what the parasite needs to make, and why it needs to make it.
Chair of the Dept of Oncology at St. Jude Children's Research Hospital and an American Cancer Society Clinical Research Professor. Recipient of the 2009 American Association for Cancer Research Team Science Award, the 2010 Castle Connolly National Physician of the Year Award, the 2011 American Association for Cancer Research Joseph H.Burchenal Clinical Research Award, 2011 American Society of Hematology Henry M. Stratton Medal, & 2012 American Soc. of Clinical Oncology Pediatric Oncology Award
Study of Medicine at the Ruprecht-Karls-Universiy in Heidelberg, Germany; Habilitation in Experimental Virology. Head of Clinical Research at the Department of Pediatrics, University Hospital Carl Gustav Carus at TU Dresden, Germany, since 1995. Speaker of Clinical Research Unit 249 "Defects of the Innate Immune System in Autoinflammation and Autoimmunity" since 2010
Senior Member of the Academy of Health Information Professionals. Recipient of the 2010 Canadian Hospital Librarian of the Year Award. Co-convener of PRESS Forum.
Professor at the school of Pediatrics - Univ. Turin. Studying nutrition, metabolism of infancy in particular hormones such as Leptin, IGF-1, Ghrelin, Adiponectin. Takes interest in gastrointestinal and nutritional disorders. He studies in detail some aspects of gut microbiota of colicky infants such low level of lactobacilli and increased concentration of E.Coli. Performed relevant research on the effect of probiotics on colicky infants. Author of more than 100 scientific reports.